Skip to main content
. 2014 Aug;55(100):16–26. doi: 10.1016/j.bioorg.2014.05.007

Fig. 4.

Fig. 4

The structure of vancomycin and its derivative chlorobiphenyl vancomycin (CBP-V), which showed antibacterial activity against vancomycin-resistant Enterococci (VRE) [85] (discussed in Section 3.5).